VBI Vaccines, Inc. (VBIV) financial statements (2021 and earlier)

Company profile

Business Address 222 THIRD STREET
CAMBRIDGE, MA 02142
State of Incorp. BC
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments11944596832
Cash and cash equivalents9444596832
Short-term investments25    
Receivables00000
Inventory, net of allowances, customer advances and progress billings21111
Inventory21111
Prepaid expense2111 
Other current assets90111
Total current assets:13247627034
Noncurrent Assets
Operating lease, right-of-use asset21
Property, plant and equipment1110922
Intangible assets, net (including goodwill)6463677268
Goodwill22898
Intangible assets, net (excluding goodwill)6261586360
Deposits noncurrent assets    0
Other noncurrent assets11110
Total noncurrent assets:7775767570
TOTAL ASSETS:209122138146105
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities41622
Accounts payable41622
Deferred revenue01
Debt 1   
Due to related parties 1512 
Deferred revenue and credits 0
Contract with customer, liability2
Other liabilities121214106
Other undisclosed current liabilities1    
Total current liabilities:173023138
Noncurrent Liabilities
Long-term debt and lease obligation171  12
Long-term debt, excluding current maturities16   12
Operating lease, liability11
Liabilities, other than long-term debt3316121
Deferred revenue and credits11
Deferred revenue33
Contract with customer, liability3
Deferred tax liabilities, net  0
Due to related parties  1312 
Other undisclosed noncurrent liabilities10000
Total noncurrent liabilities:204161313
Total liabilities:3834392621
Stockholders' equity
Stockholders' equity attributable to parent172889812084
Common stock404285246202133
Additional paid in capital7666636159
Accumulated other comprehensive income (loss)1(1)(4)1(3)
Accumulated deficit(309)(262)(208)(144)(105)
Total stockholders' equity:172889812084
TOTAL LIABILITIES AND EQUITY:209122138146105

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues12311
Cost of revenue(9)(8)(5)(5)(4)
Gross profit:(8)(6)(1)(4)(3)
Operating expenses(45)(55)(64)(38)(25)
Other undisclosed operating income98554
Operating loss:(44)(52)(60)(37)(25)
Nonoperating income (expense)
(Foreign Currency Transaction Gain (Loss), before Tax)
0(0)(1)10
Interest and debt expense(3)(2)(3)3(0)
Loss from continuing operations before equity method investments, income taxes:(46)(55)(64)(34)(25)
Other undisclosed loss from continuing operations before income taxes   (6) 
Loss from continuing operations before income taxes:(46)(55)(64)(39)(25)
Income tax benefit   02
Net loss available to common stockholders, diluted:(46)(55)(64)(39)(23)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net loss:(46)(55)(64)(39)(23)
Other comprehensive income (loss)2 (5)4(2)
Comprehensive loss:(44)(55)(69)(35)(25)
Other undisclosed comprehensive income, net of tax, attributable to parent 3   
Comprehensive loss, net of tax, attributable to parent:(44)(51)(69)(35)(25)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: